Characterization of non-homogeneous polymers with size-exclusion chromatography by implementing an on-line viscometer

The viscosity distribution of a polymer sample can be obtained by using an on-line viscometer as a detector in size-exclusion chromatography. This newly defined viscosity distribution is closely related to the molecular weight distribution and expresses weight fraction times intrinsic viscosity of species i as a function of the corresponding molecular weight times intrinsic viscosity (w_i[η_i] vs. M_i[η_i]). The intrinsic viscosity ([η]) and number-average molecular weight (M?_n) can be obtained directly from a viscosity distribution. If the Mark-Houwink exponent a is known (or approximately known) for non-homogeneous polymer the M?_w/M?_n can be estimated from the viscosity distribution when the molecular weight distribution is approximated with a known distribution function. These estimates are independent of any other detector and are valid even for non-homogeneous polymer samples. The relation between the moments of the viscosity distribution and the M?_w/M?_n is presented for two widely used distribution functions, the Log-Normal and the Generalized Exponential Distributions. Polymer characterization based on the viscosity distribution is shown to be a robust technique. It is particularly attractive in characterizing non-homogeneous polymers since it is solely obtained from on-line viscometer.     

Two-Year Follow-Up of a Randomized Clinical Trial of Inpatient Multimodal Occupational Rehabilitation Vs Outpatient Acceptance and Commitment Therapy for Sick Listed Workers with Musculoskeletal or Common Mental Disorders

Journal of Occupational Rehabilitation - Purpose There is a lack of results on long-term effects of return to work interventions. We previously reported that an inpatient multimodal occupational...     

A pilot study of recombinant interferon beta (IFN-βser) in patients with recurrent glioma

Recombinant interferon beta (IFN-_ser) has been administered by intravenous bolus injection three times weekly at a dose of 90 × 10⁶ IU to 14, patients with recurrent malignant glioma in an ongoing study. The treatment period has ranged from 1 to 40 weeks. The most common adverse experiences were fever, chills, malaise, and headache. Fever, chills and headache were worse with the first two doses and were usually relieved with acetaminophen. All patients tolerated subsequent treatments without any difficulties. No neurologic or hematologic toxicities were observed. Of ten evaluable patients, five had progressive disease in 4 to 8 weeks; three had stable disease for 12 to 21 weeks; one has had a minor response for 13 weeks; and one has had a complete resolution of tumor for 150 + weeks. IFN-_ser appears to have activity in human glioma and is well tolerated at this dosage and schedule.     

Solution properties and light scattering measurements of poly(2,5-pyrimidinediylterephthalamide)

A Series of chains of different molecular weight of the fully aromatic polyamide poly(2,5-pyrimidinediylterephthalamide)

1 IUPAC name: poly(2,5-pyrimidinediyliminoterephthaloylimino).

(PPYMT) in the solvents 96 wt.-% sulfuric acid and methanesulfonic acid have been characterized by means of static and dynamic light scattering, dilute solution viscosimetry and measurements of the critical polymer volume fraction for the onset of a nematic phase. The experimental results are in good agreement with a model of stiff worm-like chains for the solution conformation of PPYMT, and the persistence length is estimated to be ca. 150 Å (lower limit: 50–100 Å).     

Differences in the response of Sprague-Dawley and Lewis rats to bezafibrate: The hypolipidemic effect and the induction of peroxisomal enzymes

The effects of bezafibrate administered at 10 and 50 mg/kg/day for 7 days to male Sprague-Dawley (SD) and Lewis rats were investigated in order to determine the interrelation between the changes in serum and hepatic lipid contents and activities of selected peroxisomal, microsomal and mitochondrial enzymes in the two rat strains. In both strains, bezafibrate effectively reduced serum and hepatic lipids, increased the liver weight, induced a proliferation of peroxisomes, and selectively elevated the activities of carnitine acetyltransferase and of the enzymes of the peroxisomal -oxidation system. Moreover, immunoblotting revealed that the drug specifically enhanced the concentration of only those peroxisomal enzymes involved in fatty acid -oxidation. The data obtained demonstrate that although the responses initiated by bezafibrate are qualitatively similar in both strains, they differ in their magnitude in a dose-dependent manner, with the Lewis strain exhibiting a more pronounced response than the SD rats. These results show that dose-dependent strain differences as well as the generally known species differences should be taken into account in pharmacological and toxicological evaluations of fibrates in rodents. Furthermore, generalization and extrapolation from rodent studies should be treated with great caution.     

"QT" pacemaker in aggregate exchange. Do old electrodes impair functional ability?

A "QT"-interval driven rate responsive pacemaker can also be implanted on the occasion of pacemaker replacement. To evaluate the electrophysiological properties and limitations of chronic leads, in 30 patients the evoked intracardiac electrogram was recorded via the chronic lead during pacemaker replacement (14 different types, mean interval after implantation 111 (25-171 months). T-wave detectability was evaluated with different pulse amplitudes (2.5 and 5.0 V) and two pacemaker systems (TX 915, Rhythmyx) with different "fast recharge" mechanisms. In particular, the T-wave signal was influenced by capacitor discharge effects. At 2.5 V output T-wave amplitude was greater than or equal to 1.5 mV in all (19) patients, who could be paced at this voltage. However, at 5 V in 9/30 patients T-wave was less than 1 mV and detection was not possible in 6/30 cases. During pacing with the newly developed "QT"-interval driven, rate-responsive pacemaker (Rhythmyx) with two fast recharge pulses, in nine investigated patients the T-wave was markedly better discriminable compared to the TX 915 pacemaker. Accordingly, in 37 patients with implanted "QT"-controlled pacemakers (TX 911): n = 13; TX 915: n = 21; Rhythmyx: n = 3. Indication for pacemaker therapy: high degree AV block: n = 24, sick-sinus syndrome: n = 13) reliable T-wave sensing was possible at 2.5 V/0.2 ms output, whereas at 5 V/2 ms no T-wave sensing could be achieved in 8/37 cases. On the occasion of pacemaker replacement the "QT"-controlled pacemaker can be implanted without intraoperative measurements, whenever a pulse amplitude less than 2.5 V is sufficient for stimulation.(ABSTRACT TRUNCATED AT 250 WORDS)     

Endometrial volume change during spontaneous menstrual cycles: volumetry by transvaginal three-dimensional ultrasound

Objective: At present, only limited data are available on endometrial volume during the menstrual cycle. Most of these studies deal with animal models and use magnetic resonance imaging for volume measuring. The application of three-dimensional ultrasound in endometrial volume estimation is the subject of this study.Setting: Patients visiting the outpatient unit of the division of endocrinology and reproductive medicine of a university hospital.Patient(s): Twenty patients with a history of a normal menstrual cycle were selected.Intervention(s): Ultrasound examinations were performed during a single menstrual cycle in addition to routine laboratory tests.Main Outcome Measure(s): Uterus-endometrial volume ratio.Result(s): Data from 18 patients could be evaluated. In 81 examinations the endometrium volume could be determined. Mean endometrial volume measured by three-dimensional ultrasound was 1.23 cm'. Mean uterus volume was 48.93 cm3. The change of the uterus-endometrial volume ratio showed a good correlation with the day of menstrual cycle. Quadratic regression analysis of volume and cycle length was R² = 0.432.Conclusion(s): Three-dimensional ultrasound allows assessment of volume data of the female internal genitalia. In this study changes of the endometrial volume in menstrual cycles were measured. Additional studies are required to give information on the clinical impact of this new technique of endometrial volume estimation.